Active Recombinant Human Procathepsin K Protein
Cat.No. : | CTSK-22H |
Product Overview : | Recombinant Human CTSK was expressed in Insect cells. |
- Specification
- Gene Information
- Related Products
- Download
Description : | Cathepsin K, a member of the papain family of cysteine proteases, acts upon proteins such as collagen, AL amyloid, kinin and elastin. It is a lysosomal protease expressed primarily in osteoclasts, but also in other cell types such as macrophages. It functions in bone remodeling and is implicated in disease states such as atherosclerosis, arthritis and pycnodysostosis. |
Source : | Insect cells |
Species : | Human |
Form : | Liquid. In 27.8µl 20mM sodium phosphate, pH 6.9, 500mM NaCl, 1 mM EDTA. |
Bio-activity : | To activate proenzyme, add 32.5mM NaOAc, pH 3.5, to 20% of procathepsin K volume (e.g., 5µl procathepsin K + 1µl 32.5mM NaOAc, pH 3.5), and incubate at room temperature for 25-30 minutes, or at +4 centigrade for approximately seven hours. |
Molecular Mass : | 35.3kDa |
Purity : | ≥95% (SDS-PAGE) |
Applications : | Useful tool to study enzyme kinetics, cleave target substrates and screen for inhibitors. |
Notes : | Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -80 centigrade. |
Stability : | Use/Stability: -80 centigrade. After initial defrost, aliquot product into individual tubes and refreeze at -80 centigrade. Avoid repeated freeze/defrost cycles and extended periods unfrozen. This enzyme is stable when stored as received under the above conditions. Procedures such as dilution of the enzme followed by refreezing could lead to loss of activity. |
Storage : | Long Term Storage: -80 centigrade |
Tag : | Non |
Gene Name : | CTSK cathepsin K [ Homo sapiens ] |
Official Symbol : | CTSK |
Synonyms : | CTSK; cathepsin K; cathepsin K (pycnodysostosis) , CTSO, CTSO2, PYCD; PKND; cathepsin O; cathepsin X; cathepsin O1; cathepsin O2; CTSO; PYCD; CTS02; CTSO1; CTSO2; MGC23107; |
Gene ID : | 1513 |
mRNA Refseq : | NM_000396 |
Protein Refseq : | NP_000387 |
MIM : | 601105 |
UniProt ID : | P43235 |
Chromosome Location : | 1q21 |
Pathway : | Immune System, organism-specific biosystem; Innate Immune System, organism-specific biosystem; Lysosome, organism-specific biosystem; Lysosome, conserved biosystem; Osteoclast Signaling, organism-specific biosystem; Osteoclast differentiation, organism-specific biosystem; Osteoclast differentiation, conserved biosystem; |
Function : | cysteine-type endopeptidase activity; cysteine-type peptidase activity; peptidase activity; |
Products Types
◆ Recombinant Protein | ||
CTSK-2111H | Recombinant Human CTSK Protein, GST-tagged | +Inquiry |
CTSK-1326R | Recombinant Rat CTSK Protein, His (Fc)-Avi-tagged | +Inquiry |
CTSK-439R | Recombinant Rat CTSK Protein (115-329 aa), His-tagged | +Inquiry |
CTSK-914R | Recombinant Rhesus Macaque CTSK Protein, His (Fc)-Avi-tagged | +Inquiry |
CTSK-2069M | Recombinant Mouse CTSK Protein, His (Fc)-Avi-tagged | +Inquiry |
◆ Lysates | ||
CTSK-7192HCL | Recombinant Human CTSK 293 Cell Lysate | +Inquiry |
◆ Assay kits | ||
Kit-2352 | Cathepsin K Inhibitor Screening Kit (Fluorometric) | +Inquiry |
Related Gene
Not For Human Consumption!
Inquiry
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewThis guidance can help researchers design and execute their experiments more effectively, ensuring reliable and accurate results.
They have a deep understanding of the CTSK protein and can provide valuable insights into its characteristics, properties, and optimal experimental conditions.
the manufacturer offers outstanding technical support, serving as a valuable resource to resolve any issues that may arise during my research.
Q&As (5)
Ask a questionYes, CTSK inhibitors are being investigated for their potential in preventing bone loss associated with periodontal diseases.
CTSK has been linked to vascular calcification in atherosclerosis, and inhibiting its activity may have potential as a therapeutic strategy for cardiovascular diseases.
CTSK inhibitors could potentially be used to limit bone destruction in cancer patients with bone metastasis, improving their quality of life.
CTSK inhibitors are being explored for potential therapeutic applications in conditions like rheumatoid arthritis and certain cancers due to their involvement in tissue remodeling.
While CTSK is not currently used as a diagnostic marker, its levels and activity could potentially be explored for diagnostic purposes in the future.
Ask a Question for All CTSK Products
Required fields are marked with *
My Review for All CTSK Products
Required fields are marked with *
Inquiry Basket